These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 4842157)
1. Recipient's hepatitis, an inevitable side-effect of blood transfusion. Fiedler H Vox Sang; 1974; 26(4):368-73. PubMed ID: 4842157 [No Abstract] [Full Text] [Related]
2. Studies on viral hepatitis and hepatitis B (Australia) antigen. Iwarson S Scand J Infect Dis Suppl; 1973; ():1-30. PubMed ID: 4204580 [No Abstract] [Full Text] [Related]
3. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Alter HJ; Holland PV; Purcell RH; Lander JJ; Feinstone SM; Morrow AG; Schmidt PJ Ann Intern Med; 1972 Nov; 77(5):691-9. PubMed ID: 4628213 [No Abstract] [Full Text] [Related]
4. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis. Hollinger FB; Aach RD; Gitnick GL; Roche JK; Melnick JL N Engl J Med; 1973 Aug; 289(8):385-91. PubMed ID: 4719826 [No Abstract] [Full Text] [Related]
5. Hepatitis B antigen and prevention of post-transfusion hepatitis B. Iwarson S; Hermodsson S; Lindholm A; Magnius L Vox Sang; 1975; 28(4):278-84. PubMed ID: 804765 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of an immunoassay for serial studies on hepatitis B antigen in blood donors]. Bütler R; Frei PC; Frey-Wettstein M; Grob PJ; Krech U; Lambert PH Schweiz Med Wochenschr; 1974 Sep; 104(38):1316-21. PubMed ID: 4421924 [No Abstract] [Full Text] [Related]
7. Letter: Hepatitis B antigen in screened blood units. Can Med Assoc J; 1974 May; 110(9):1008 passim. PubMed ID: 4823103 [No Abstract] [Full Text] [Related]
8. Asymptomatic hapatic disease in blood donors with hepatitis B antigenemia. Vittal SB; Dourdourekas D; Shobassy N; Gerber M; Telischi M; Szanto PB; Steigmann F; Clowdus BF Am J Clin Pathol; 1974 Nov; 62(5):649-54. PubMed ID: 4412110 [No Abstract] [Full Text] [Related]
9. [Technics of detection of Australia antigen and corresponding antibodies in blood transfusion centers]. Vranckx R Arch Belg Med Soc; 1973 Apr; 31(4):222-54. PubMed ID: 4202183 [No Abstract] [Full Text] [Related]
10. The significance of Australia-antibody in blood donors. Study of liver histology in donors and post-transfusion hepatitis in recipients. Reinicke V; Poulsen H; Banke O; Dybkjaer E Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):753-6. PubMed ID: 4205739 [No Abstract] [Full Text] [Related]
11. Risk of transfusing blood containing antibody to hepatitis-B surface antigen. Aach RD; Alter HJ; Hollinger FB; Holland PV; Lander JJ; Melnick JL; Weiler JM Lancet; 1974 Jul; 2(7874):190-3. PubMed ID: 4135609 [No Abstract] [Full Text] [Related]
13. [Australia antigen and its relationship to viral hepatitis (a review of the literature)]. Golosova TV; Margolina AN Lab Delo; 1973; 6():323-7. PubMed ID: 4129381 [No Abstract] [Full Text] [Related]
19. [Clinical, epidemiological and biochemical study of a population of blood donors carrying Australia antigen and hepatitis B]. Chicot D; Delaruelle S Rev Fr Transfus; 1974 Mar; 17(1):75-85. PubMed ID: 4408945 [No Abstract] [Full Text] [Related]
20. Post-Konyne hepatitis: the ineffectiveness of screening for the hepatitis B antigen (HBAg). Sandler SG; Rath CE; Wickerhauser M; Dodd RY; Greenwalt TJ Transfusion; 1973; 13(4):221-4. PubMed ID: 4198439 [No Abstract] [Full Text] [Related] [Next] [New Search]